Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Perlis, R. H. Articles by Nierenberg, A. A. Search for Related Content PubMed Citation Articles by Perlis, R. H. Articles by Nierenberg, A. A. Other Ethics Issues

Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry

OBJECTIVE: Financial conflict of interest has been reported to be prevalent in clinical trials in general medicine and associated with a greater likelihood of reporting results favorable to the intervention being studied. The extent and implications of industry sponsorship and financial conflict of interest in psychiatric clinical trials have not been investigated, to the authors’ knowledge. METHOD: The authors examined funding source and author financial conflict of interest in all clinical trials published in the American Journal of Psychiatry, the Archives of General Psychiatry, the Journal of Clinical Psychopharmacology, and the Journal of Clinical Psychiatry between 2001 and 2003. RESULTS: Among 397 clinical trials identified, 239 (60%) reported receiving funding from a pharmaceutical company or other interested party, and 187 studies (47%) included at least one author with a reported financial conflict of interest. Among the 162 randomized, double-blind, placebo-controlled studies examined, those that reported conflict of interest were 4.9 times more likely to report positive results; this association was significant only among the subset of pharmaceutical industry-funded studies. CONCLUSIONS: Author conflict of interest appears to be prevalent among psychiatric clinical trials and to be associated with a greater likelihood of reporting a drug to be superior to placebo.

This article has been cited by other articles:

				J. K. Chan, S. M. Ueda, V. E. Sugiyama, C. D. Stave, J. Y. Shin, B. J. Monk, B. I. Sikic, K. Osann, and D. S. Kapp Analysis of Phase II Studies on Targeted Agents and Subsequent Phase III Trials: What Are the Predictors for Success? J. Clin. Oncol., March 20, 2008; 26(9): 1511 - 1518. [Abstract] [Full Text] [PDF]

				R. P. Riechelmann, L. Wang, A. O'Carroll, and M. K. Krzyzanowska Disclosure of Conflicts of Interest by Authors of Clinical Trials and Editorials in Oncology J. Clin. Oncol., October 10, 2007; 25(29): 4642 - 4647. [Abstract] [Full Text] [PDF]

				L. A. Hampson, S. Joffe, R. Fowler, J. Verter, and E. J. Emanuel Frequency, Type, and Monetary Value of Financial Conflicts of Interest in Cancer Clinical Research J. Clin. Oncol., August 20, 2007; 25(24): 3609 - 3614. [Abstract] [Full Text] [PDF]

				C. Barbui and A. Cipriani Publication Bias in Systematic Reviews Arch Gen Psychiatry, July 1, 2007; 64(7): 868 - 868. [Full Text] [PDF]

				Bibliography PSYCHOPHARMACOLOGY Focus, September 1, 2006; 4(4): 512. [Full Text] [PDF]

				J. H. MONTGOMERY Industry Funding and Author-Industry Affiliation in Clinical Trials in Psychiatry Am J Psychiatry, June 1, 2006; 163(6): 1110 - 1111. [Full Text] [PDF]

				L. J. Kirmayer Beyond the 'New Cross-cultural Psychiatry': Cultural Biology, Discursive Psychology and the Ironies of Globalization Transcultural Psychiatry, March 1, 2006; 43(1): 126 - 144. [Abstract] [PDF]

				Industry Sponsorship, Conflicts of Interest, and Reported Results Journal Watch Psychiatry, November 2, 2005; 2005(1102): 2 - 2. [Full Text]

				R. Daly Positive Clinical-Trial Results Linked to Competing Interests Psychiatr News, October 21, 2005; 40(20): 26 - 27. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2005 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us